Expanded Access Use of Stiripentol in Participants With Dravet Syndrome or Epileptic Encephalopathies Associated With Sodium Channel Mutations

Trial Profile

Expanded Access Use of Stiripentol in Participants With Dravet Syndrome or Epileptic Encephalopathies Associated With Sodium Channel Mutations

Recruiting
Phase of Trial: Phase II

Latest Information Update: 11 Aug 2016

At a glance

  • Drugs Stiripentol (Primary)
  • Indications Dravet syndrome; Encephalopathy; Epilepsy
  • Focus Adverse reactions; Expanded access; Therapeutic Use
  • Most Recent Events

    • 16 Sep 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top